Significance of Thyroglobulin Autoantibodies in Patients With Thyroid Cancer Treated With Lenvatinib.
Daniele SgròPiercarlo RossiPaolo PiaggiAlessandro BrancatellaLoredana LorussoValeria BotticiEleonora MolinaroFrancesco LatrofaRossella EliseiLaura AgatePublished in: Journal of the Endocrine Society (2023)
TgAb evaluation may represent a reliable surrogate marker for Tg trend in evaluating response of RAIR-DTC to treatment with lenvatinib. A multicentric study would be useful to confirm our results.